After a Record-Setting Week, Wall Street Turns to Inflation Data and the First Big Earnings Reports

The S&P 500 reached a record and ended the week at 7,811.54, while the 10-year Treasury yield closed at 5.24%, its highest level since 2002; the week also included sharp stock moves after a proposed SpaceX spectrum acquisition, with T-Mobile down 13.3% and Crown Castle up 15.6% on Friday. Humana gained 11.6% after reporting that 95% of its Medicare Advantage members are in plans rated at least 4 stars for 2027, and it affirmed 2026 adjusted EPS guidance of at least $9.00. PepsiCo raised its organic revenue outlook to about 3% but reduced its core EPS growth outlook to 2.5%-3.5%; markets are looking ahead to September CPI and major third-quarter earnings reports.

Analysis

The equity/rates divergence is the near-term risk: with long yields elevated, Wednesday’s CPI and Thursday’s PPI can reprice duration-sensitive equities even if earnings headlines remain supportive. A benign print may sustain the rally; another inflation surprise, especially alongside oil above $90, raises the odds that multiples compress before earnings estimates adjust.

The wireless reaction looks ahead of the economics. SpaceX’s spectrum access could eventually pressure carrier pricing or bargaining power in rural coverage, but FCC approval, compatible devices and commercial terms remain gating items. Satellite coverage is not an obvious substitute for dense-network capacity, and towers’ long-duration leases do not become more valuable simply because carriers sold off. The sharp move in American Tower (AMT) and Crown Castle (CCI) may therefore be flow-driven rather than evidence of a durable earnings upgrade. T-Mobile (TMUS), AT&T (T) and Verizon (VZ) face uncertainty, not yet demonstrated revenue displacement.

Humana’s (HUM) member share in higher-rated plans is encouraging but is not itself an earnings bridge: payment and benefit effects depend on CMS mechanics, plan-level ratings and enrollment. The 11.6% rebound risks getting ahead of that verification. UnitedHealth (UNH) results are a useful read-through on medical-cost trends, but not a direct confirmation of HUM’s star-rating economics. Delta’s (DAL) fuel-cost absorption makes sustained high oil a margin test; PepsiCo’s (PEP) slower core-EPS outlook despite revenue growth points to a margin/earnings-quality question. The contrarian risk is treating upbeat company-specific news as insulation from rates and input costs.

Key Decisions for Investors

• Keep broad equity exposure hedged into CPI/PPI rather than adding beta after index highs; reassess if inflation data ease and long yields retreat, and reduce the hedge only if yields stabilize without earnings-guidance deterioration.
• Do not chase the CCI/AMT rally or extrapolate the carrier selloff into a confirmed structural winner/loser trade. Track FCC approval, spectrum-use conditions, handset compatibility and disclosed carrier/SpaceX commercial agreements; these are the evidence needed to size a relative-value position.
• Treat HUM’s ratings outcome as a catalyst to verify, not an earnings upgrade: compare plan-level ratings and 2027 payment implications with December guidance before adding after the sharp rebound. Use UNH’s Tuesday medical-care disclosures as sector context, not a substitute for HUM-specific confirmation.
• Monitor DAL’s fuel assumptions against crude prices and PEP’s core-EPS/margin commentary. Persistent oil strength or further earnings-guidance reductions would weaken the case that demand resilience alone protects these companies’ profit outlooks.